Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid.» Read More
Marcus Rivaldi, executive director at Twelve Capital, outlines the opportunities for insurers in emerging markets.
Paul Geddes, CEO of Directline, says the insurance company is always interested in opportunities that could include M&A.
AXA posted a 2 percent increase in net income as a fall in the value of financial assets reduced the benefit of a weak euro on its earnings.
For health insurers, government health programs have become an increasingly important part of their business.
PartnerRe, which had a $6.6 billion merger agreement with Axis Capital, reached a deal with rival suitor Exor to be acquired for $6.9 billion.
There were sharp decreases among uninsured people in Texas and California, but the rate among Hispanics continues to be relatively high.
California lawsuit accuses CVS of overcharging some customers for generic drugs.
Alan Miller, Universal Health Services CEO, discusses how rising health care costs and an aging population are impacting the health service sector.
CNBC's Phil LeBeau reports on questions and concerns raised about Ford's F-150.
David Cordani, Cigna Corp. president & CEO, discusses antitrust questions that have surfaced around its pending deal with Anthem. And Cordani weighs in on drug affordability and containing prices.
The Defense Department has tapped medical records firm Cerner and its partners Leidos and Accenture to help overhaul the military's massive health IT system.
Apart from the vibrant potential that Southeast Asia holds, Lloyd's of London is also keen to provide opportunities for ASEAN companies to do business in the U.K., says chairman John Nelson.
By 2024, national health expenditures are forecast to be $5.43 trillion annually, according to a new estimate.
States that expanded Medicaid programs saw bigger gains in insured rates, as well as access to doctors and medicines, than other states.
A new study finds that many major auto insurance companies are adding to the grief by raising rates for new widows by as much as 226 percent.
Customers of the largest state-run Obamacare exchange can see price cuts if they move out of their current plans.
Companies spend huge sums to get things into space, but an average of 1 in 20 launches fail. That's why they need insurance.
These challenges could lead more of them to turn over operations to the federal government or join forces with other states.
One large pharmacy benefit manager warns that costs from new PCSK9 drugs could reach as high as $150 billion annually.
Japan's Meiji Yasuda Life Insurance said it has agreed to buy U.S.-based StanCorp Financial for $5 billion, the latest deal by Japanese insurers.